Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin

Ramezani, Mazaher; Mohamadzaheri, Elham; Khazaei, Sedigheh; Najafi, Farid; Vaisi-Raygani, Asad; Rahbar, Mahtab; Sadeghi, Masoud

추천

검색

자료유형: 학술저널

저자정보: Ramezani, Mazaher (Molecular Pathology Research Center, Emam Reza University Hospital) Mohamadzaheri, Elham (Molecular Pathology Research Center, Emam Reza University Hospital) Khazaei, Sedigheh (Molecular Pathology Research Center, Emam Reza University Hospital) Najafi, Farid (Department of Biostatistics and Epidemiology, Kermanshah University of Medical Sciences) Vaisi-Raygani, Asad (Department of Clinical Biochemistry, Kermanshah University of Medical Sciences) Rahbar, Mahtab (Molecular Pathology Research Center, Emam Reza University Hospital) Sadeghi, Masoud (Cancer Research Center, Kermanshah University of Medical Sciences)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제3호

발행연도: 2016.1

수록면: 1,379 - 1,383 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Basal and squamous cell carcinoma (BCC and SCC) are the most common skin cancers worldwide and distinction between the two may sometimes be very difficult in routine histopathology. The present study was aimed to evaluate a reliable diagnostic method for these cancers based on immunohistochemistry (IHC). Materials and Methods: IHC was used with antibodies to Bcl-2, CD10, CEA, and EMA biomarkers, which despite non-specificity are easily available for detection of various types of tumors in pathology sections and can be used as a panel for differentiation. In this descriptive and analytic study, paraffin-embedded blocks of 29 SCC patients and 29 BCC patients were collected and sectioned for IHC staining. The results were analyzed by the STATA (version 8) statistical package using the Chi-square test. Results: BCC patients were 100%, 75.8%, 0% and 0% positive for Bcl-2, CD10, CEA and EMA markers, respectively, and for SCC patients were 3.5%, 0%, 34.5% and 82.7% positive, respectively. Using simultaneously Bcl-2 and CD10 as positive markers, detection of BCC with 88% accuracy and 100% specificity was possible, while application of CEA and EMA positivity could detect SCC with 67% accuracy and 100% specificity. Conclusions: SCC and BCC have different immunostaining profiles; therefore, Bcl-2, CD10, CEA and EMA markers can be helpful to distinguish between them.

#Skin cancer #BCC #SCC #differential diagnosis #immunohistochemistry #markers

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!